A warm welcome to our new CEO, Dr. Sven K. Weber!
We’re delighted to have you on board. It’s an exciting moment for BRAIN Biotech, and we’re ready to shape the next chapter together.
#brainbiotech#newCEO#biotechnology
📢#BRAINBiotech receives a EUR 11.51m milestone payment from Royalty Pharma following positive clinical progress for #deucrictibant. Further payments of up to EUR 96.65m may follow - strengthening BRAIN’s financial position and core business.
👉 https://t.co/jOy591yxHg
We have published our 9M financial figures for the 2025/26 fiscal year. Find the respective press release at https://t.co/084J5giXQT
#biotech#bioeconomy#enzymes
The Supervisory Board of BRAIN Biotech AG has appointed Dr. Sven K. Weber to the Executive Board effective October 1, 2026, and named him the future Chairman of the Board (CEO).
Press release: https://t.co/cldVIWpW1W
@BRAINbiotech has been granted a key patent for its CRISPR BMC #genomeediting technology. This #patent opens significant potential for the further commercial application of the patented nucleases.
Press release: https://t.co/DaqDhx4CEZ
We have published our #financialfigures for the first three months of the 2025/26 FY. We have also announced news about our participation project with SolasCure and Aurase Wound Gel as part of the BRAINBioIncubator. https://t.co/ixo9ypqnXx
#biotech#enzymes#Investments
Our #AnnualReport for FY 2024/25 is here! Take a look at the highlights of the BRAIN Biotech Group’s journey over the past year. Report: https://t.co/eB78jj2eMz
Press release: https://t.co/DaqDhx4CEZ
#biotechnology#AnnualReport
„Mittelstandsreise“ führte Parlamentarische Staatssekretärin Gitta Connemann nach Zwingenberg - Artikel im Bergsträsser Anzeiger - https://t.co/VAcjOIxkkX
BRAIN Biotech has appointed Johan Jansén-Storbacka as EVP of the BRAINBiocatalysts´ #enzyme products business.
Find the respective press release at https://t.co/DaqDhx4CEZ
@BRAINbiotech and @CorbionFood have reached agreement to collaborate in the development of novel bio-based antimicrobial compounds and its derivatives.
Find the respective press release at https://t.co/435wX7Li0H
#futurefood#foodindustry#biosolution
We´ve bought out the remaining minority shares in our Dutch subsidiary Breatec B.V. With the closure of this transaction, all businesses in the #BRAINBiocatalysts division are now fully owned by @brainbiotechag
Press release: https://t.co/DaqDhx4CEZ
#BakerySolutions#Enzymes
@BRAINbiotech has published its #financialfigures for the first three months of the FY2024/25. We are now reporting for the first time under our new two-pillar reporting structure with the segments BRAINBiocatalysts and BRAINBioIncubator.
Press release: https://t.co/DaqDhx4CEZ
@BRAINbiotech and PX Group announce collaboration within the framework of the PX #UrbanMining Initiative – after having developed a proof of concept for the biological recovery of #gold from e-waste and other gold-containing side streams.
Press release: https://t.co/DaqDhx5aux